Ciphergen s SELDI Tech Helps Harvard Team Identify Likely Cancer Biomarker | GenomeWeb

NEW YORK, April 8 - Researchers at Harvard University have used protein-chip technology developed by Ciphergen Biosystems to identify a biomarker that might lead to faster detection of ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.